相关实验视频
Updated: Jun 18, 2025
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.4K
在恒定电流下对震抑制策略的研究 帕金森病的外周电刺激装置
概括
一种新的电刺激器有效地减少了帕金森病的震,使用向的神经和肌肉刺激. 这种可穿戴设备为震管理提供了一个有希望的,非侵入性的和具有成本效益的替代方案.
科学领域:
- 生物医学工程 生物医学工程
- 神经科学是一个神经科学.
- 医疗器械 医疗器械
背景情况:
- 帕金森病 (PD) 休息震显著影响生活质量.
- 传统的治疗方法,如药物治疗和手术,具有包括副作用和成本在内的局限性.
- 需要有效的,非侵入性的震抑制方法.
研究的目的:
- 开发和评估用于帕金森病的轻量级电刺激器.
- 评估新型协收缩回避刺激 (CAS) 策略的有效性.
- 探索用于震管理的外围电刺激.
主要方法:
- 开发了一种可编程参数的FPGA驱动的恒流电刺激器.
- 实施了两个CAS策略:辐射神经和肌肉刺激.
- 在四名帕金森病患者身上进行了临床实验,使用惯性传感器获取运动数据.
- 通过平均角速幅度和刺激后抑制率来测量减.
主要成果:
- CAS策略将手指关节的角速度幅度降低了75.92% (神经) 和82.41% (肌肉).
- 低频肌肉刺激实现了59.91%的震抑制率,在刺激后5分钟内,当电流<8mA时.
- 开发的刺激器在特定参数下表现出有效的震抑制.
结论:
- 轻量级的恒流电刺激器有效地抑制了帕金森病的震.
- 外围电刺激,特别是针对肌肉的CAS,显示出显著的治疗潜力.
- 这些发现支持开发可穿戴,非侵入性和经济高效的震抑制装置.
更多相关视频
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
14.7K
08:22Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
Published on: October 7, 2017
8.1K
相关概念视频
01:24Parkinson's Disease: Treatment
241
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
241
01:15Parkinson's Disease: Overview
510
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
510